Bookimed does not add extra charges for Breast cancer treatment prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your treatment upon your arrival to the country.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Breast cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Breast cancer treatment journey.
| Italy | Turkey | Austria | |
| Tomotherapy | - | from $10,000 | from $1,000 |
| Radiotherapy for breast cancer | - | from $700 | - |
| Radiation therapy for colorectal cancer | - | from $3,250 | - |
| Mastectomy | - | from $4,500 | - |
Ospedale San Raffaele (San Raffaele Research Hospital) in Milan is one of the largest research hospitals in Europe. It applies ad hoc methods for rare immune system and genetic diseases treatment.
Among its achievements — the world's first stem cell therapy for patients with severe combined immune deficiency disorder (ADA-SCID).
Oncology, oncohematology, neurosurgery, neurology, cardiovascular surgery, urology, and gynecology are the strongest specialities here.
Surgeons of the hospital perform over 52,000 operations annually.
Policlinico San Donato is a leading Italian clinic for cardiology and cardiac surgery.
Doctors perform over 9,400 open and minimally invasive operations on the heart and blood vessels annually. It is the largest number in the country.
Сardiology, heart surgery, arrhythmology, and rehabilitation are the top specialities in San Donato Hospital.
Doctor Oreste Gentilini is an Italian specialist in breast cancer treatment with over 20 years of experience, providing over 5,000 breast cancer surgeries. He is the head of the Breast Unit in San Raffaele Hospital and the SOUND study at the European Institute of Oncology of Milan. He has authored over 100 papers on breast tumors treatment, with a focus on breast cancer management in young women and pregnant patients. He is a founding member and Vice President of EU-BREAST, and a member of the board of directors of the Italian National Association of Senologists and Surgeons (ANISC).
Dr. Giuseppe Curigliano is the head of the Division of Early Drug Development at the European Institute of Oncology and an Associate Professor of Medical Oncology at the University of Milano in Italy. He is the founding member and scientific chair for the International Cardio-Oncology Society (ICOS) and has received the first ESO Umberto Veronesi Award in Vienna in 2017 and the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.